Skip to main content

Table 1

From: Quantitative assessment of diffuse myocardial fibrosis and edema in patients with and without cardiac involvement of sarcoidosis by cardiovascular magnetic resonance T1- and T2-mapping at 1.5T

  Age (years) LVEDV (ml) IVSD (mm) EF (%) T1 (ms) T2 (ms)
Group 1 (n=10) 51,80 ± 28,28 134,55 ± 42,42 9,11 ± 0,71 58,78 ± 7,07 1009,30 ± 13,44 (p <0,05) 54 ± 1,41
Group 2 (n=6) 54,33 ± 5,66 117 ± 21,92 9,20 ± 1,06 60,8 ± 18,38 988 ± 10,61 54,17 ± 2,12
Group 3 (n=8) 55,13 ± 11,31 110,57 ± 16,26 9,69 ± 0,71 66,50 ± 1,41 1001,86 ± 0,71 54,50 ± 2,08
Group 4 (n=20) 50,60 ± 31,82 150,40 ± 61,52 9,96 ± 0,71 62,55 ± 4,24 957,65 ± 15,56 52,95 ± 4,95
  1. Patient characteristics as well as T1 and T2 relaxation times.